# Technical Investor Validation Report

**Date:** 2026-02-26 (execution completed through 2026-02-27 UTC)  
**Repository:** HDIM (`master`)  
**Review Method:** Coordinated SWE + QA review with executed validation matrix

## Executive Outcome

- **Operational release gate (strict production profile): GO**
- **Validation matrix run: PASS (with documented caveats)**
- **Remaining diligence blocker:** documented security audit contradictions must be explicitly reconciled with current implementation evidence.

## Executed Validation Matrix

1. `./validate-system.sh`
   - Result: `PASS` (exit 0)
   - Artifact: `test-results/validate-system-2026-02-26.log`

2. `npm run test:mcp`
   - Result: `PASS` (10/10 tests)
   - Artifacts:
     - `test-results/test-mcp-2026-02-26.log`
     - `test-results/test-mcp-postfix-2026-02-26.log`

3. `npm run e2e:clinical-portal:smoke`
   - Result: `PASS` (5/5 Playwright smoke checks)
   - Artifact: `test-results/e2e-clinical-portal-smoke-2026-02-26.log`

4. `bash scripts/security/validate-phase4-hipaa-controls.sh`
   - Result: `PASS`
   - Artifact: `test-results/hipaa-controls-2026-02-26.log`

5. `npm run mcp:operator:go-no-go:target` (strict, production profile)
   - Result: `GO=true` (confirmed on consecutive runs)
   - Artifacts:
     - `logs/mcp-reports/operator-go-no-go-20260227-001448.md`
     - `logs/mcp-reports/operator-go-no-go-20260227-001710.md`
     - `logs/mcp-reports/release-gate-20260227-001707.md`

## Key Evidence Highlights

- Strict release gate summary shows:
  - `pass: true`
  - `readiness: true`
  - `tenantPolicyPass: true`
  - `runningServices: 19`
- Operator report confirms all orchestration steps passed:
  - pretest
  - release-gate
  - evidence-pack
  - controlled-restart
  - evidence-package

## Caveats and Residual Risk

- `validate-system.sh` output still includes non-blocking caveats (for example AI endpoints returning 404 in this profile, and demo data nuances) while overall script exits `0`.
- Existing security audit document (`docs/SECURITY_AUDIT_FINDINGS.md`) still records historical critical findings. Investor packet should include an explicit delta section: what is closed, what remains, and what compensating controls exist.

## Recommended Diligence Package Attachments

1. Latest strict go/no-go report (`operator-go-no-go-20260227-001710.md`).
2. Latest strict release gate report (`release-gate-20260227-001707.md`).
3. System validation log (`validate-system-2026-02-26.log`).
4. UI smoke log (`e2e-clinical-portal-smoke-2026-02-26.log`).
5. HIPAA control log (`hipaa-controls-2026-02-26.log`).
6. MCP regression test log (`test-mcp-postfix-2026-02-26.log`).

## Final Recommendation

- **GO for technical demo and operational readiness narrative**, backed by executed artifacts above.
- **Conditional GO for full investor diligence narrative** once security-audit contradiction is reconciled in a single signed status document.
